Consistent with our study, ATG5 and PRKN were identified as risk genes (27, 29, 30), whereas, CDKN2A and NLRP1 predicted favorable survivals of HNSCC (28–33). This evidence concerns the gene NLRP1 and head and neck squamous cell carcinoma.